NEW YORK (AP) _ Rocket Pharmaceuticals Inc. (RCKT) on Thursday reported a loss of $60.9 million in its fourth quarter.

The New York-based company said it had a loss of $1.08 per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.

For the year, the company reported that its loss widened to $139.7 million, or $2.52 per share.

Rocket Pharmaceuticals shares have increased 2% since the beginning of the year. The stock has more than doubled in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RCKT at https://www.zacks.com/ap/RCKT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News